Skip to main content
. 2021 Jun 24;138(16):1429–1440. doi: 10.1182/blood.2021011719

Figure 3.

Figure 3

Hematopoietic recovery. Analysis was performed in the as-treated population (n = 108). Cumulative incidence of neutrophil engraftment by day 42 (A) and platelet recovery by day 100 (B) among recipients of omidubicel or unmanipulated UCB.